StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck scope 3 GHG — Category 5: Waste Generated in Operations (metric tons CO2e)

Merck Impact Report

Latest, FY2025
81,400
Period ended Dec 31, 2025
Change on a year earlier
-12.9%
93,500 in FY2024
History
6 years
Since FY2019
Sources
1
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedScope 3 GHG — Category 5: Waste Generated in Operations (metric tons CO2e)Year on yearSource
FY2025Dec 31, 202581,400-12.9%–
FY2024Dec 31, 202493,500+9.0%–
FY2023Dec 31, 202385,800-20.9%–
FY2022Dec 31, 2022108,500+5.0%–
FY2021Dec 31, 2021103,300––
FY2019Dec 31, 201989,000––

Cite this data

StockData. (2026). Merck Scope 3 GHG — Category 5: Waste Generated in Operations (metric tons CO2e), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/esg_ghg_s3_c5

See every metric in the Merck KPI table. Data updated Oct 26, 2026.